| Pharmaceutical Information |
| Drug Name |
Carbimazole |
| Drug ID |
BADD_D00360 |
| Description |
An imidazole antithyroid agent. Carbimazole is metabolized to methimazole, which is responsible for the antithyroid activity. |
| Indications and Usage |
For the treatment of hyperthyroidism and thyrotoxicosis. It is also used to prepare patients for thyroidectomy. |
| Marketing Status |
approved; investigational |
| ATC Code |
H03BB01 |
| DrugBank ID |
DB00389
|
| KEGG ID |
D07616
|
| MeSH ID |
D002231
|
| PubChem ID |
31072
|
| TTD Drug ID |
D02CKX
|
| NDC Product Code |
Not Available |
| UNII |
8KQ660G60G
|
| Synonyms |
Carbimazole | Carbimazole Henning | Neo-Thyreostat | Neomercazole | Neo-Mercazole | Neo Tomizol |
|
| Chemical Information |
| Molecular Formula |
C7H10N2O2S |
| CAS Registry Number |
22232-54-8 |
| SMILES |
CCOC(=O)N1C=CN(C1=S)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
